Blue Edge Capital, LLC - VANECK VECTORS ETF TR ownership

VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 715 filers reported holding VANECK VECTORS ETF TR in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.6%.

Quarter-by-quarter ownership
Blue Edge Capital, LLC ownership history of VANECK VECTORS ETF TR
ValueSharesWeighting
Q4 2021$2,662,718,000
+1.6%
83,132
-6.5%
0.51%
-6.0%
Q3 2021$2,620,797,000
-13.3%
88,931
-0.0%
0.55%
-12.8%
Q2 2021$3,023,099,000
+126.9%
88,967
+117.0%
0.63%
+111.8%
Q1 2021$1,332,467,000
-9.1%
40,999
+0.8%
0.30%
-16.4%
Q4 2020$1,465,294,000
-5.7%
40,680
+2.5%
0.35%
-16.3%
Q3 2020$1,554,495,00039,6960.42%
Other shareholders
VANECK VECTORS ETF TR shareholders Q4 2020
NameSharesValueWeighting ↓
New Harbor Financial Group, LLC 1,221,955$36,011,00014.81%
New Harbor Financial Group, LLC 1,155,900$34,064,00014.01%
Memorial Sloan Kettering Cancer Center 738,500$21,764,00013.56%
Hollow Brook Wealth Management LLC 670,275$19,753,00012.24%
Grand Central Investment Group 293,243$8,642,00011.46%
BW Gestao de Investimentos Ltda. 940,800$27,725,0008.44%
Slate Path Capital LP 5,930,000$174,757,0007.97%
Nokomis Capital, L.L.C. 512,628$15,107,0007.14%
Plaisance Capital LLC 288,000$8,487,0006.05%
Guild Investment Management, Inc. 200,114$5,897,0005.68%
View complete list of VANECK VECTORS ETF TR shareholders